Pulmatrix
Latest round
- Series B
Last raised
- Aug 2011
Total raised
- $49M
Investors
- 4
About Pulmatrix
Pulmatrix, Inc.Founded in 2003, Pulmatrix, Inc. specializes in therapeutic development for respiratory conditions.2 million.PULMATRiX specializes in advanced pulmonary-delivered therapeutics utilizing its proprietary iSPERSE™ technology. This innovative approach focuses on enhancing patient care by providing efficient delivery systems for medications aimed at addressing serious respiratory diseases. The company's core product offerings improve drug absorption in the lungs, optimizing treatment outcomes for conditions such as asthma and chronic obstructive pulmonary disease (COPD).40 mn.Pulmatrix, Inc. plans to expand its product line and enhance market presence by developing new pulmonary-delivered therapeutics, leveraging its iSPERSE™ technology. The company aims to expand into additional markets within Europe and Asia by 2025, targeting regions with increasing demands for effective respiratory therapies. Further, the strategic focus includes enhancing partnerships with healthcare systems to improve accessibility to its products.
Who invested in Pulmatrix
4 investors across 7 rounds
See all investors in Pulmatrix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 15, 2011
Amount
$14M
Investors
Series B
Aug 6, 2010
Amount
$2M
Investors
Series B
Oct 16, 2009
Amount
$15M
Investors
Series A
Sep 3, 2008
Amount
$4M
Investors
Series A
May 29, 2007
Amount
$8M
Investors
Seed
Apr 24, 2007
Amount
$2.7M
Investors
Series A
Mar 24, 2006
Amount
$2.7M
Investors
Questions about Pulmatrix
Who invested in Pulmatrix?
Pulmatrix has 4 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pulmatrix raised?
Pulmatrix has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Pulmatrix last raise money?
Pulmatrix's most recent round on record is a Series B, in Aug 2011.
What does Pulmatrix do?
Pulmatrix is a biotechnology company.
Where is Pulmatrix headquartered?
Pulmatrix is headquartered in US.
Which VCs invest in companies like Pulmatrix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pulmatrix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pulmatrix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.